Free Trial

IRIDEX (IRIX) Competitors

IRIDEX logo
$1.02 +0.03 (+2.59%)
As of 11:56 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IRIX vs. HYPR, ICAD, CTSO, MBOT, TELA, APT, ECOR, APYX, INO, and TMDIF

Should you be buying IRIDEX stock or one of its competitors? The main competitors of IRIDEX include Hyperfine (HYPR), iCAD (ICAD), Cytosorbents (CTSO), Microbot Medical (MBOT), TELA Bio (TELA), Alpha Pro Tech (APT), electroCore (ECOR), Apyx Medical (APYX), Inovio Pharmaceuticals (INO), and Titan Medical (TMDIF). These companies are all part of the "medical equipment" industry.

IRIDEX vs.

IRIDEX (NASDAQ:IRIX) and Hyperfine (NASDAQ:HYPR) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, community ranking, earnings and profitability.

In the previous week, IRIDEX had 1 more articles in the media than Hyperfine. MarketBeat recorded 9 mentions for IRIDEX and 8 mentions for Hyperfine. Hyperfine's average media sentiment score of 0.68 beat IRIDEX's score of 0.40 indicating that Hyperfine is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IRIDEX
0 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Hyperfine
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

IRIDEX presently has a consensus price target of $2.00, indicating a potential upside of 95.12%. Hyperfine has a consensus price target of $1.33, indicating a potential upside of 84.21%. Given IRIDEX's higher probable upside, analysts plainly believe IRIDEX is more favorable than Hyperfine.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IRIDEX
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Hyperfine
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

IRIDEX received 266 more outperform votes than Hyperfine when rated by MarketBeat users. Likewise, 63.11% of users gave IRIDEX an outperform vote while only 50.00% of users gave Hyperfine an outperform vote.

CompanyUnderperformOutperform
IRIDEXOutperform Votes
272
63.11%
Underperform Votes
159
36.89%
HyperfineOutperform Votes
6
50.00%
Underperform Votes
6
50.00%

IRIDEX has higher revenue and earnings than Hyperfine. IRIDEX is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IRIDEX$48.43M0.35-$9.57M-$0.67-1.53
Hyperfine$12.89M4.36-$44.24M-$0.56-1.29

IRIDEX has a net margin of -22.79% compared to Hyperfine's net margin of -309.42%. Hyperfine's return on equity of -57.54% beat IRIDEX's return on equity.

Company Net Margins Return on Equity Return on Assets
IRIDEX-22.79% -192.95% -33.97%
Hyperfine -309.42%-57.54%-50.38%

IRIDEX has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Comparatively, Hyperfine has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500.

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 15.0% of Hyperfine shares are owned by institutional investors. 7.3% of IRIDEX shares are owned by company insiders. Comparatively, 29.4% of Hyperfine shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

IRIDEX beats Hyperfine on 9 of the 17 factors compared between the two stocks.

Remove Ads
Get IRIDEX News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IRIX vs. The Competition

MetricIRIDEXElectromedical equipment IndustryComputer SectorNASDAQ Exchange
Market Cap$17.05M$3.31B$22.48B$7.68B
Dividend YieldN/A1.63%2.83%4.02%
P/E Ratio-1.5314.4641.3918.55
Price / Sales0.3543.421,962.1688.66
Price / CashN/A44.0934.7334.64
Price / Book1.743.355.954.11
Net Income-$9.57M$94.03M$736.56M$247.18M
7 Day Performance7.89%-3.66%-3.61%-4.05%
1 Month Performance-25.72%-12.81%49,731.19%-6.41%
1 Year Performance-65.60%-20.98%52,818.84%-2.08%

IRIDEX Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IRIX
IRIDEX
1.1625 of 5 stars
$1.03
+2.6%
$2.00
+95.1%
-66.5%$17.05M$48.43M-1.53120Earnings Report
Gap Down
HYPR
Hyperfine
3.65 of 5 stars
$0.83
+1.2%
$1.33
+60.2%
-28.0%$60.56M$12.89M-1.46190High Trading Volume
ICAD
iCAD
0.5475 of 5 stars
$2.28
+2.2%
N/A+32.9%$60.51M$19.61M-17.54140
CTSO
Cytosorbents
2.0572 of 5 stars
$1.03
+4.7%
$4.67
+353.1%
+5.3%$56.32M$33.79M-2.86220
MBOT
Microbot Medical
1.6249 of 5 stars
$1.60
-5.9%
$9.00
+462.5%
+18.7%$55.59MN/A-2.0020Earnings Report
TELA
TELA Bio
2.7847 of 5 stars
$1.40
-4.8%
$7.25
+417.9%
-78.2%$55.14M$68.65M-0.83120Gap Up
High Trading Volume
APT
Alpha Pro Tech
N/A$5.05
+0.6%
N/A-19.6%$54.91M$57.84M13.65120Analyst Forecast
ECOR
electroCore
2.6852 of 5 stars
$7.43
-7.1%
$25.50
+243.2%
+4.5%$53.44M$25.18M-4.0650Short Interest ↑
High Trading Volume
APYX
Apyx Medical
2.6179 of 5 stars
$1.38
+9.5%
N/A-4.4%$52.16M$48.10M-1.66270Gap Up
INO
Inovio Pharmaceuticals
3.8451 of 5 stars
$1.88
-2.1%
$12.20
+548.9%
-87.5%$49.07M$217,756.00-0.47320
TMDIF
Titan Medical
N/A$0.43
flat
N/A+647.6%$49.04M$17.63M-0.3450
Remove Ads

Related Companies and Tools


This page (NASDAQ:IRIX) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners